200 related articles for article (PubMed ID: 33540004)
1. PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery.
Raza A; Miles JA; Sime FB; Ross BP; Roberts JA; Popat A; Kumeria T; Falconer JR
Int J Pharm; 2021 Mar; 597():120280. PubMed ID: 33540004
[TBL] [Abstract][Full Text] [Related]
2. Liquid CO
Raza A; Sime FB; Cabot PJ; Roberts JA; Falconer JR; Kumeria T; Popat A
ACS Biomater Sci Eng; 2021 May; 7(5):1836-1853. PubMed ID: 33438994
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
4. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
[TBL] [Abstract][Full Text] [Related]
6. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
8. Characterization and application of roxithromycin loaded cyclodextrin based nanoparticles for treatment of multidrug resistant bacteria.
Masood F; Yasin T; Bukhari H; Mujahid M
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():1-7. PubMed ID: 26838816
[TBL] [Abstract][Full Text] [Related]
9. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
Zu Y; Wu W; Zhao X; Li Y; Zhong C; Zhang Y
Int J Pharm; 2014 Dec; 477(1-2):148-58. PubMed ID: 25455767
[TBL] [Abstract][Full Text] [Related]
10. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
11. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.
Alhowyan AA; Altamimi MA; Kalam MA; Khan AA; Badran M; Binkhathlan Z; Alkholief M; Alshamsan A
J Microbiol Methods; 2019 Jun; 161():87-95. PubMed ID: 30738109
[TBL] [Abstract][Full Text] [Related]
12. The binary complex of poly(PEGMA-co-MAA) hydrogel and PLGA nanoparticles as a novel oral drug delivery system for ibuprofen delivery.
Shang Q; Huang S; Zhang A; Feng J; Yang S
J Biomater Sci Polym Ed; 2017 Nov; 28(16):1874-1887. PubMed ID: 28693380
[TBL] [Abstract][Full Text] [Related]
13. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
14. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
15. Polymer Nanoparticles with 2-HP-β-Cyclodextrin for Enhanced Retention of Uptake into HCE-T Cells.
Qin Z; Li B; Deng Q; Wen Y; Feng S; Duan C; Zhao B; Li H; Gao Y; Ban J
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338402
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
17. Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.
Gidwani B; Vyas A
Pharm Dev Technol; 2016 Mar; 21(2):161-71. PubMed ID: 25391288
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery.
Raza A; Alavi SE; Sime FB; Han FY; Roberts JA; Popat A; Falconer JR; Kumeria T
Acta Biomater; 2021 May; 126():277-290. PubMed ID: 33774198
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
